FASEB J. Innocentive
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by WESTBERG, J. A.
Right arrow Articles by ANDERSSON, L. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by WESTBERG, J. A.
Right arrow Articles by ANDERSSON, L. C.
(The FASEB Journal. 1999;13:1621-1626.)
© 1999 FASEB

Regulation of neural differentiation by normal and mutant (G654A, amyloidogenic) gelsolin

JOHAN A. WESTBERG*, KE-ZHOU ZHANG* and LEIF C. ANDERSSON*,{dagger}1

Department of Pathology, Helsinki University Hospital and
* Haartman Institute, University of Helsinki, Finland; and
{dagger} Karolinska Institute and Hospital, Stockholm, Sweden

1Correspondence: University of Helsinki, Haartman Institute, Department of Pathology, P.O. Box 21 (Haartmaninkatu 3), FIN-00014 Helsinki, Finland. E-mail: Leif.Andersson{at}helsinki.fi


   ABSTRACT
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
 
Gelsolin belongs to a family of proteins that modulate the structural dynamics of cytoskeletal actin. Gelsolin activity is required for the redistribution of actin occurring during membrane ruffling, cell crawling, and platelet activation. A point mutation (G654A) in the gelsolin gene causes a dominantly inherited systemic amyloidosis called familial amyloidosis of the Finnish type (FAF). This disease is characterized by a cranial neuropathy that cannot be explained solely by amyloid deposits. To address the question of whether gelsolin has a specific role in neural cell development, we transfected cDNA for wild type and G654A point-mutated gelsolin into a neural cell line, Paju, which can be induced to differentiate by treatment with phorbol 12-myristate 13-acetate. Overexpressed wild type gelsolin inhibited neural differentiation whereas mutated gelsolin did not, indicating that appropriate gelsolin activity is essential for neural sprouting. The G654A mutant gelsolin induced stabilization of F-actin and reduced the plasticity of neural development. This provides a novel etiopathogenetic mechanism for the neuronal dysfunction in FAF.—Westberg, J. A., Zhang, K.-Z., Andersson, L. C. Regulation of neural differentiation by normal and mutant (G654A, amyloidogenic) gelsolin.


Key Words: PMA • neural sprouting • familial amyloidosis of the Finnish type (FAF) • brain


   INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
 
GELSOLIN, A MEMBER of a family of proteins that modulate the structural dynamics of cytoskeletal actin, sequesters and caps monomeric G-actin, and can sever and cap the barbed ends of polymerized F-actin filaments (1) . The activity of gelsolin is stimulated by Ca2+ and/or low pH, which promotes its association to actin filaments (2) . The gelsolin molecule consists of six structurally related 15 kDa domains. These form a compact globular structure in a Ca2+-free environment (3) , in which the putative actin binding sequences are not sufficiently exposed to bind actin. A rise in Ca2+ or lowered pH is proposed to release connections joining the amino- and carboxyl-terminal halves of the molecule, thereby allowing the molecule to adopt its active configuration. Polyphosphoinositides, particularly phosphatidylinositol 4,5-bisphosphate (PIP2)2 (2) , down-regulate the activity of gelsolin by inducing its dissociation from actin (4 , 5) . There is also evidence indicating that the in vivo levels of Ca2+ and PIP2 may regulate the compartmental distribution of gelsolin between the membrane-associated cytoskeleton and the cytosol (reviewed in ref 1 ).

The gene for human gelsolin is located on chromosome 9q32-q34 (6) . It codes for cytoplasmic gelsolin and a secreted plasma form of gelsolin that carries an additional amino-terminal extension of 23 amino acids. Both the cytoplasmic and secreted forms of gelsolin are expressed in most adult tissues (7) . The expression pattern in the developing rat brain (8) , where initial low levels of gelsolin are followed by increased expression levels around day 10 and a subsequent decrease around day 30, suggests that gelsolin activity is involved in early brain development.

A single nucleotide substitution G654 to A654 in the genomic DNA sequence of gelsolin (9 , 10) replaces aspartic acid at residue 187 with asparagine, giving rise to Finnish type familial amyloidosis (FAF), an autosomal dominant disease. The mutation exposes a novel protease cleavage site in the mature gelsolin protein, which is the proposed mechanism responsible for the generation of the amyloidogenic fragment. An accumulation of the amyloid material gives rise to a systemic amyloidosis characterized by corneal lattice dystrophy, skin changes, renal complications, and a neuropathy that affects the cranial nerves in particular (11) . Furthermore, plasma gelsolin isolated from FAF patients has been shown to have a defective actin-severing activity in vitro (12) .

The neuropathy occurring in FAF includes signs of decreased conductibility and demyelination (13) . The amount of amyloid found in the vicinity of nerves does not, however, satisfactorily explain the severity of the neuropathy. This raises the question of whether the presence of mutated gelsolin directly impairs neural functions. To address this question, we created stable transfectants of wild type and G654 to A654 point-mutated gelsolin in the human, neural crest-derived Paju cell line.

We demonstrate that gelsolin activity is a regulator of neural differentiation. Overexpression of wild type gelsolin inhibited neural sprouting induced by treatment with phorbol 12-myristate 13-acetate (PMA). The induced sprouting, however, which requires actin polymerization, was not affected by overexpression of mutated gelsolin.


   MATERIALS AND METHODS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
 
Plasmid constructs
The 5'-most 2.1 kb of the human plasma gelsolin cDNA clone M1D in pUC13 (14) was subcloned into the expression vector pcDNA3 (Invitrogen, The Netherlands). The G654 to A654 point mutation was introduced by polymerase chain reaction (PCR) mutagenesis, using 5'-TCAACAATGGCAACTGCTTCATCCTG-3' and 5'-CAGGATGAAGCAGTTGCCATTGTTGA-3' as inside primers containing the point mutation. As outside primers, 5'-CGAGTTCCTCAAGGCAGGGA-3' and 5'-CACGGGCACCTTGTTGGAAC-3' were used. A 1137 bp BglII fragment was excised from the native sequence and substituted with the corresponding 1137 bp mutated PCR fragment. Sequence integrity was verified by sequencing.

Cells
The Paju tumor cell line was established in our laboratory from the pleural fluid of a 16-year-old girl who had a widespread, metastatic neural crest-derived tumor. The cells grow surface adherent and were cultivated in RPMI 1640 medium, supplemented with 5% fetal calf serum (FCS), penicillin G (10 U/ml), streptomycin sulfate (50 mg/ml), and 1 mM glutamine. For subculturing, the cells were detached by treatment with Versene/EDTA (Gibco BRL, Grand Island, N.Y.). PMA was obtained from Sigma (St. Louis, Mo.), dissolved in ethanol, and used at an optimal concentration of 10 nM. Paju cells were transfected with the vector construct using lipofectamine reagent according to the instructions of the manufacturer (Gibco BRL). Transfected cells were selected for resistance to G418 (700 µg/ml) and single-cell cloned. All experimental results were confirmed with separate single-cell cloned cell lines of the wild type and G654A gelsolin transfected Paju cells.

Western blotting
The cells were detached and washed with phosphate-buffered saline (PBS), lysed in ice-cold Pawson lysis buffer containing 50 mM HEPES (pH 7.0), 150 mM NaCl, 10% glycerol, 1% Triton X-100, 1.5 mM MgCl2, 1 mM EGTA, 100 mM NaF, 10 mM NaPPi, 1 mM orthovavadate, 1 mM PMSF, and 10 mg/ml each of aprotinin and leupeptin. The samples were centrifuged at 14,000 x g for 5 min and the supernatants were collected. An aliquot was removed for total protein estimation using Bio-Rad protein assay (Bio-Rad Laboratories, Hercules, Calif.). An aliquot corresponding to 20 µg of total protein of each sample was separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis under reducing conditions and transferred electrophoretically to nitrocellulose filters. Nonspecific binding of antibody was blocked with 3% bovine serum albumin in PBS/0.1% Triton X-100 for 1 h. Immunoblotting was carried out with the respective antibody, followed by peroxidase-conjugated secondary anti-immunoglobulin (anti-Ig) antibodies, and the blots were developed by the enhanced chemiluminescence method (Amersham, U.K.). Monoclonal antibodies to gelsolin and ß-actin were purchased from Sigma. Immunoprecipitation was carried out by incubating the gelsolin antibody for 2 h at +4°C with the cell lysates, followed by an incubation for 1 h with agarose-conjugated goat anti-mouse IgG antibody (Sigma). Monoclonal anti-CD20 (Oy Medix AB, Finland) was used as a control antibody. Precipitated proteins were eluted with Laemmli sample buffer and used for Western blotting.

Cell staining
Cells were grown on coverslips in the presence of 10 nM PMA for 2 days. The coverslips were collected, rinsed in PBS, fixed in 3.5% paraformaldehyde, and carefully rinsed three times in PBS. The cells were permeabilized with PBS/0.05% Triton X-100 for 10 min and rinsed in PBS. For phalloidin staining, the coverslips were incubated for 45 min with a 13 U/ml dilution of rhodamine-conjugated phalloidin (Molecular Probes, Eugene, Oreg.) in PBS. The coverslips were rinsed three times in PBS and mounted in glycerol:PBS (1:1) for microscopic analysis. The cells stained for gelsolin were incubated for 15 min in PBS/2% FCS, followed by incubation for 1 h with the gelsolin antibody diluted 1:150 in PBS/2% FCS. The coverslips were rinsed three times in PBS/2% FCS and incubated for 45 min with a fluorescein isothiocyanate-conjugated goat anti-mouse antibody (DAKO A/S, Glostrup, Denmark) diluted 1:20 in PBS/2% FCS. The coverslips were rinsed three times in PBS/2% FCS and mounted in glycerol:PBS (1:1) for microscopic analysis.


   RESULTS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
 
Overexpression of gelsolin in neural cells
To study the in vivo effect of the G654A mutated gelsolin that occurs in FAF patients, we transfected a human neural cell line (Paju) with the 5'-most 2.1 kb of cDNA for wild type (WT) and mutated (G654A) gelsolin (Fig. 1 A). The gelsolin encoded by the transfected cDNA had a carboxyl-terminal truncation and was therefore easily distinguishable from the endogenous gelsolin. Carboxyl-terminal truncation of gelsolin is known to result in a loss of calcium requirement for filament severing and monomer binding (15) . This ensured that the transfected gelsolin was constitutively active and allowed us to study its effect regardless of internal or external calcium stimuli. Clones of transfected Paju cells expressing equal amounts of WT gelsolin and G654A gelsolin were selected. The level of overexpression in the transfected cells studied was densitometrically measured to be 2.4-fold the endogenous level for the wild type and 3.8-fold the endogenous level for the G654A clone. Cells transfected with the empty vector served as controls. Since gelsolin is also secreted as plasma gelsolin, we assayed the amounts of secreted gelsolin in conditioned media of the various transfected clones (Fig. 1B ). Relatively large amounts were secreted as compared to control clones containing the empty vector (pcDNA3). A differential electrophoretic pattern was observed between the secreted WT and G654A gelsolins. It is known that the proteolytic cleavage of mutant gelsolin differs from normal gelsolin (16) and leads to the production of the amyloidogenic fragment.



View larger version (32K):
[in this window]
[in a new window]
 
Figure 1. A) Immunoblot analysis of endogenous and transfected levels of gelsolin protein in Paju cells transfected with the empty pcDNA3 vector (pcDNA3), truncated wild type gelsolin (WT), or truncated G654 to A654 point-mutated gelsolin (G654A). B) Immunoblot analysis of gelsolin levels in conditioned media from cells transfected with the control vector (pcDNA3), truncated wild type (WT), or mutated (G654A) gelsolin.

Overexpression of WT gelsolin and G654A gelsolin had strikingly different effects on the shape of Paju cells. By 10 h after plating, the G654A gelsolin overexpressing cells already displayed a flat, polygonic morphology with tiny cytoplasmic protrusions, whereas the WT overexpressing cells retained their round shape (Fig. 2 A). The Paju cells transfected with the empty vector and untransfected cells had acquired an intermediate morphology. This prompted us to investigate the impact of gelsolin overexpression on PMA-induced neural sprouting.



View larger version (115K):
[in this window]
[in a new window]
 
Figure 2. A) Phase-contrast photomicrographs of Paju cells transfected with the control empty vector (pcDNA3), wild type gelsolin (WT), or point-mutated gelsolin (G654A). The upper panel shows morphology 10 h after plating. The lower panel shows morphology after 48 h of 10 nM PMA treatment. B) Effect of treatment with 10 nM PMA for 0, 24, and 48 h on gelsolin expression in Paju cells transfected with the empty vector (pcDNA3), wild type (WT), or point-mutated (G654A) gelsolin cDNA.

Effect of gelsolin on PMA-induced neural differentiation
When exposed to PMA, Paju cells undergo neural differentiation by producing extensive neurite outgrowths. Cells overexpressing WT or G654A gelsolin were treated with 10 nM PMA for 2 days (Fig. 2A ). Control cells and cells overexpressing G654A gelsolin responded by characteristic neurite outgrowths, whereas cells overexpressing WT gelsolin displayed a completely different behavior. Treatment with PMA did not induce typical neural sprouting, and the cells acquired only some short cytoplasmic protrusions (Fig. 2A ). The endogenous levels of gelsolin were not affected by PMA treatment (Fig. 2B ) in any of the cell clones.

Since one of the major roles of gelsolin is to modify actin filaments, and the organization of the actin cytoskeleton is largely decisive for the cellular shape, we stained F-actin in PMA-treated cells with rhodamine-phalloidin (Fig. 3 ). The slender neurite-like extensions of PMA-treated control cells or cells overexpressing G654A gelsolin contained long polymerized actin cables. These were absent from the cells overexpressing WT gelsolin. Taken together with the previously reported loss of actin-severing ability in vitro of plasma gelsolin isolated from FAF patients (12) , our findings suggest that the different responses to PMA treatment of cells overexpressing WT or G654A gelsolin could be due to the reported defective severing ability of mutated cytoplasmic gelsolin in vivo.



View larger version (52K):
[in this window]
[in a new window]
 
Figure 3. Immunofluorescence photomicrographs of cells grown in the presence of 10 nM PMA for 2 days and stained with rhodamine-conjugated phalloidin. A) Paju cells transfected with the empty pcDNA3 vector. B) Paju cells overexpressing wild type gelsolin. C) Paju cells overexpressing G654A point-mutated gelsolin.

Actin binding of wild type and mutant gelsolin
To investigate whether the morphological differences between the transfected Paju cells were due to the inability of the mutant gelsolin to bind to actin, we immunoprecipitated gelsolin and measured the amount of coprecipitated actin (Fig. 4 ). The amount of coprecipitated actin was identical for both wild type and mutant gelsolin, showing that no differences exist in the monomeric actin binding capacity of WT and mutated gelsolin.



View larger version (61K):
[in this window]
[in a new window]
 
Figure 4. ß-actin coprecipitates both with WT and G654A truncated gelsolin. Lysates of Paju cells transfected with the empty vector (pcDNA3), wild type (WT), or point-mutated (G654A) gelsolin cDNA were immunoprecipitated with antibodies to gelsolin. The precipitates and total cell lysates were immunoblotted with antibodies to ß-actin (A). The same filter was reblotted with antibodies to gelsolin (B). IgH indicates the immunoglobulin heavy chain.

Distribution of wild type and mutated gelsolin in Paju cells
Knowing the impact of WT gelsolin vs. G654A gelsolin on the induced neural differentiation, we investigated by indirect immunofluorescence the distribution of gelsolin in control Paju cells and in cells transfected with the gelsolin cDNA constructs. A membrane-associated immunoreactivity was seen in the control cells, with more intense staining in the emerging growth cones and neurite extensions. In the Paju cells transfected with the gelsolin constructs, the overexpressed protein seemed to accumulate, at least partially, in surface-associated aggregates. This resembles previous reports of endogenous gelsolin immunostaining of rat fibroblasts (17) . In cells overexpressing G654A gelsolin, these intensely staining aggregates were also seen along the neurite-like extensions (Fig. 5 ). Immunostaining with the secondary antibody alone did not display any reactivity (data not shown). Analysis of gelsolin amounts in fractionated cell lysates, however, did not reveal any differences in subcellular localization of WT and G654A gelsolin (data not shown).



View larger version (75K):
[in this window]
[in a new window]
 
Figure 5. Immunofluorescence photomicrographs of cells grown in the presence of 10 nM PMA for 2 days and stained for gelsolin. A) Paju cells transfected with the empty pcDNA3 vector. B) Paju cells transfected with wild type gelsolin. C) Paju cells transfected with point-mutated gelsolin. Due to the low level of staining for the endogenous gelsolin, panel A was photographed at a higher magnification in order to visualize gelsolin localized in the neural processes (arrows). Arrows in panel C show aggregates of gelsolin in the neural processes.


   DISCUSSION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
 
Gelsolin is of paramount importance for cellular functions involving rapid reorganization of the actin cytoskeleton. These include activities like migration and rapid changes in the shape of the cells in response to stimuli [i.e., triggering of the thrombin receptor on platelets (18 , 19) ]. The functional role of gelsolin became particularly evident from studies of gelsolin (-/-) knockout mice (20) . Although gelsolin was not required for normal embryonal development or growth of the mouse, defective platelet shape changes caused prolonged bleeding times, neutrophile migration was impaired, and skin fibroblasts displayed excessive actin stress fibers and lowered migratory capacity. Chen et al. (21) also reported that gelsolin plays a central role in epidermal growth factor receptor-induced cell motility, and Azuma et al. (22) recently provided evidence for gelsolin acting as a downstream effector of rac (a member of the rho family of GTPases) in fibroblast membrane ruffling. Together, these observations indicate that gelsolin activity is required at sites where rapid modification of the membrane actin-cytoskeleton takes place.

Our findings demonstrate that gelsolin activity is involved in the regulation of morphological differentiation of a neural cell line. In fact, the extensive neural differentiation displayed by the Paju cell model offers a sensitive cellular readout for gelsolin activity. It is conceivable that strictly regulated gelsolin activity is required not only to create and maintain the extended actin cables forming a cytoskeletal core in neuronal processes, but also to maintain the growth cones representing the lamellipodia of sprouting neurons.

Overexpression of wild type and mutant gelsolin had a dramatic effect on the behavior of the neural cell line Paju. This was already clearly seen shortly after plating of the cells. Paju cells overexpressing WT gelsolin remained rounded for a prolonged period of time, whereas cells containing overexpressed mutant gelsolin rapidly acquired a flat polygonic shape with developed actin stress fibers. This difference was even more pronounced after induction of differentiation by treatment with PMA. Whereas overexpressed WT gelsolin prevented neural sprouting, the G654A mutated gelsolin did not inhibit the polymerization of long actin filaments necessary for dendritic extensions to form. The fundamental importance of gelsolin activity for neural differentiation is also evident from the findings of Lu et al. (23) . Cultured hippocampal neurons from gelsolin (-/-) null mice were shown to have delayed or absent retraction of filopodia on the extending neurites as compared to hippocampal neurons from normal mice. An excess of gelsolin would conceivably prevent the formation of filopodial structures, as seen in Paju cells overexpressing WT gelsolin.

The different action of WT vs. G654A mutant gelsolin on neural sprouting is not due to altered actin binding capacity. Coprecipitation with antibodies to gelsolin brought down equal amounts of actin. Also, no notable difference in intracellular distribution of overexpressed WT and G654A gelsolin could be detected by indirect immunofluorescence or cellular fractionation studies. Therefore, together with the previously reported defective actin-severing activity, in vitro, of plasma gelsolin isolated from FAF patients (12) , it appears that our findings may be attributed to defective in vivo actin-severing activity of the G654A mutated gelsolin.

The cells overexpressing G654A gelsolin acquired a polygonic shape more rapidly than control Paju cells. This implies stabilization of the actin filaments, which may lead to reduced plasticity during development of the neural system in FAF patients. The slower cell cycle progress of Paju cells overexpressing G654A gelsolin is also in line with this notion (J. A. Westberg et al., unpublished observations). These observations suggest that mutant gelsolin may be exerting dominant negative activity. Moreover, our in vitro findings provide a pathogenetic mechanism for the dominant autosomal inheritance of FAF.

The effects seen by overexpression of mutant gelsolin may explain some of the symptoms of FAF patients. It has been suggested that gelsolin is involved in the lamellipodial movement of myelin-forming cells to wrap axons by modulation of their actin polymerization (8) . The aberrant actin modulation of mutated gelsolin in FAF patients would therefore impair the efficiency of the myelination of axons, which could explain the electrophysiological findings of Kiuru and Seppäläinen (13) , i.e., signs of slow nerve conduction and prolonged distal motor latencies suggestive of demyelination. The deregulation of neural process formation in itself would also contribute to the neuropathy of FAF patients. In conclusion, it is evident that the neuropathy of FAF patients is not only caused by amyloid deposits, but appears to arise as a combination of amyloid deposits and a loss of function of the cellular gelsolin protein. These findings, in turn, reveal an important function for gelsolin in normal neural development.


   ACKNOWLEDGMENTS
 
This study was supported by the K. Albin Johansson Foundation, The Sigrid Jusélius Foundation, The Finnish Academy of Science, The Finnish Cancer Society, The Novo Nordisk Fonden, and The Swedish Cancer Society. We thank Anneli Asikainen, Hannele Laaksonen, and Hilkka Toivonen for technical assistance.


   FOOTNOTES
 
2 Abbreviations: PIP2, phosphatidylinositol 4,5-bisphosphate; FAF, Finnish type familial amyloidosis; Ig, immunoglobulin; PMA, phorbol 12-myristate 13-acetate; FCS, fetal calf serum; PBS, phosphate-buffered saline; PCR, polymerase chain reaction; WT, wild type.

Received for publication January 25, 1999. Revised for publication April 24, 1999.


   REFERENCES
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
 

  1. Schafer, D. A., Cooper, J. A. (1995) Control of actin assembly at filament ends. Annu. Rev. Cell. Dev. Biol. 11,497-518[Medline]
  2. Lamb, J. A., Allen, P. G., Tuan, B. Y., Janmey, P. A. (1993) Modulation of gelsolin function. Activation at low pH overrides Ca2+ requirement. J. Biol. Chem. 268,8999-9004[Abstract/Free Full Text]
  3. Burtnick, L. D., Koepf, E. K., Grimes, J., Jones, E. Y., Stuart, D. I., McLaughlin, P. J., Robinson, R. C. (1997) The crystal structure of plasma gelsolin: implications for actin severing, capping, and nucleation. Cell 90,661-670[Medline]
  4. Janmey, P. A., Lida, K., Yin, H. L., Stossel, T. P. (1987) Polyphosphoinositide micelles and polyphosphoinositide-containing vesicles dissociate endogenous gelsolin-actin complexes and promote actin assembly from the fast-growing end of actin filaments blocked by gelsolin. J. Biol. Chem. 262,12228-12236[Abstract/Free Full Text]
  5. Janmey, P. A., Stossel, T. P. (1987) Modulation of gelsolin function by phosphatidylinositol 4,5-bisphosphate. Nature (London) 325,362-364[Medline]
  6. Kwiatkowski, D. J., Westbrook, C. A., Bruns, G. A., Morton, C. C. (1988) Localization of gelsolin proximal to ABL on chromosome 9. Am. J. Hum. Genet. 42,565-572[Medline]
  7. Paunio, T., Kangas, H., Kiuru, S., Palo, J., Peltonen, L., Syvänen, A. C. (1997) Tissue distribution and levels of gelsolin mRNA in normal individuals and patients with gelsolin-related amyloidosis. FEBS Lett 406,49-55[Medline]
  8. Tanaka, J., Sobue, K. (1994) Localization and characterization of gelsolin in nervous tissues: gelsolin is specifically enriched in myelin-forming cells. J. Neurosci. 14,1038-1052[Abstract]
  9. Maury, C. P., Kere, J., Tolvanen, R., de la Chapelle, A. (1990) Finnish hereditary amyloidosis is caused by a single nucleotide substitution in the gelsolin gene. FEBS Lett 276,75-77[Medline]
  10. Maury, C. P., Alli, K., Baumann, M. (1990) Finnish hereditary amyloidosis. Amino acid sequence homology between the amyloid fibril protein and human plasma gelsolin. FEBS Lett. 260,85-87[Medline]
  11. Maury, C. P., Kere, J., Tolvanen, R., de la Chapelle, A. (1992) Homozygosity for the Asn187 gelsolin mutation in Finnish-type familial amyloidosis is associated with severe renal disease. Genomics 13,902-903[Medline]
  12. Weeds, A. G., Gooch, J., McLaughlin, P., Maury, C. P. (1993) Variant plasma gelsolin responsible for familial amyloidosis (Finnish type) has defective actin severing activity. FEBS Lett 335,119-123[Medline]
  13. Kiuru, S., Seppäläinen, A. M. (1994) Neuropathy in familial amyloidosis, Finnish type (FAF): electrophysiological studies. Muscle Nerve 17,299-304[Medline]
  14. Kwiatkowski, D. J., Stossel, T. P., Orkin, S. H., Mole, J. E., Colten, H. R., Yin, H. L. (1986) Plasma and cytoplasmic gelsolins are encoded by a single gene and contain a duplicated actin-binding domain. Nature (London) 323,455-458[Medline]
  15. Kwiatkowski, D. J., Janmey, P. A., Yin, H. L. (1989) Identification of critical functional and regulatory domains in gelsolin. J. Cell Biol. 108,1717-1726[Abstract/Free Full Text]
  16. Maury, C. P., Sletten, K., Totty, N., Kangas, H., Liljeström, M. (1997) Identification of the circulating amyloid precursor and other gelsolin metabolites in patients with G654A mutation in the gelsolin gene (Finnish familial amyloidosis): pathogenetic and diagnostic implications. Lab. Invest. 77,299-304[Medline]
  17. Wang, E., Yin, H. L., Krueger, J. G., Caliguiri, L. A., Tamm, I. (1984) Unphosphorylated gelsolin is localized in regions of cell-substratum contact or attachment in Rous sarcoma virus-transformed rat cells. J. Cell Biol. 98,761-771[Abstract/Free Full Text]
  18. Hartwig, J. H., Chambers, K. A., Stossel, T. P. (1989) Association of gelsolin with actin filaments and cell membranes of macrophages and platelets. J. Cell Biol. 108,467-479[Abstract/Free Full Text]
  19. Hartwig, J. H. (1992) Mechanisms of actin rearrangements mediating platelet activation. J. Cell Biol. 118,1421-1442[Abstract/Free Full Text]
  20. Witke, W., Sharpe, A. H., Hartwig, J. H., Azuma, T., Stossel, T. P., Kwiatkowski, D. J. (1995) Hemostatic, inflammatory, and fibroblast responses are blunted in mice lacking gelsolin. Cell 81,41-51[Medline]
  21. Chen, P., Murphy Ullrich, J. E., Wells, A. (1996) A role for gelsolin in actuating epidermal growth factor receptor-mediated cell motility. J. Cell Biol. 134,689-698[Abstract/Free Full Text]
  22. Azuma, T., Witke, W., Stossel, T. P., Hartwig, J. H., Kwiatkowski, D. J. (1998) Gelsolin is a downstream effector of rac for fibroblast motility. EMBO J 17,1362-1370[Medline]
  23. Lu, M., Witke, W., Kwiatkowski, D. J., Kosik, K. S. (1997) Delayed retraction of filopodia in gelsolin null mice. J. Cell Biol. 138,1279-1287[Abstract/Free Full Text]



This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
J. H. Song, C. X. Wang, D. K. Song, P. Wang, A. Shuaib, and C. Hao
Interferon {gamma} Induces Neurite Outgrowth by Up-regulation of p35 Neuron-specific Cyclin-dependent Kinase 5 Activator via Activation of ERK1/2 Pathway
J. Biol. Chem., April 1, 2005; 280(13): 12896 - 12901.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
D. J. Hernandez-Deviez, M. G. Roth, J. E. Casanova, and J. M. Wilson
ARNO and ARF6 Regulate Axonal Elongation and Branching through Downstream Activation of Phosphatidylinositol 4-Phosphate 5-Kinase {alpha}
Mol. Biol. Cell, January 1, 2004; 15(1): 111 - 120.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
J. Kanungo, Z. Kozmik, S. K. Swamynathan, and J. Piatigorsky
Gelsolin is a dorsalizing factor in zebrafish
PNAS, March 18, 2003; 100(6): 3287 - 3292.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by WESTBERG, J. A.
Right arrow Articles by ANDERSSON, L. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by WESTBERG, J. A.
Right arrow Articles by ANDERSSON, L. C.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS